Leveraging technological and R&D strength, Artivila has established a global pipeline portfolio of small-molecule drugs with high innovation and commercial potential. Artivila is currently focused on Autoimmune diseases, Neurodegenerative diseases and Cancers, where there is a huge unmet need for treatment.